Nivolumab in pre-treated malignant pleural mesothelioma: real-world data from the Dutch expanded access program

BACKGROUND: Randomized phase III trials are ongoing to investigate the efficacy of nivolumab in malignant pleural mesothelioma (MPM), but real-world data are still scarce. In this real-world study, we investigated the clinical outcomes of nivolumab treatment in pre-treated MPM patients. METHODS: Dat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Transl Lung Cancer Res
Main Authors: Cantini, Luca, Belderbos, Robert A., Gooijer, Cornedine J., Dumoulin, Daphne W., Cornelissen, Robin, Baart, Sara, Burgers, Jacobus A., Baas, Paul, Aerts, Joachim G. J. V.
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7481613/
https://ncbi.nlm.nih.gov/pubmed/32953495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-19-686
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados